Economy

Johnson & Johnson Vaccine Is 66% Effective In Preventing Moderate To Severe COVID-19

By Scott Hensley
Published January 29, 2021 at 5:30 AM PST
  • Facebook
  • Twitter
  • LinkedIn
  • Email
Economy
  • Facebook
  • Twitter
  • LinkedIn
  • Email
Scott Hensley
Scott Hensley edits stories about health, biomedical research and pharmaceuticals for NPR's Science desk. During the COVID-19 pandemic, he has led the desk's reporting on the development of vaccines against the coronavirus.
See stories by Scott Hensley